About Afraxis
Afraxis is a company based in San Diego (United States) founded in 2007. It operates as a B2B. Afraxis has raised $2 million across 5 funding rounds from investors including HHS. Afraxis operates in a competitive market with competitors including Cellply, Lucid Scientific, Kiyatec, CytoTronics and Saguaro, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Jurisdiction Bangalore North, Karnataka, India
-
Annual Revenue
$403.09 K (USD)19.31as on Mar 31, 2022
-
Net Profit
$26.11 K (USD)-14.87as on Mar 31, 2022
-
EBITDA
$31.2 K (USD)28.43as on Mar 31, 2022
-
Total Equity Funding
$2 M (USD)
in 5 rounds
-
Latest Funding Round
$204.51 K (USD), Grant
Sep 15, 2017
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Afraxis
Afraxis has successfully raised a total of $2M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $204.51 thousand completed in September 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Grant — $204,508
-
First Round
First Round
(08 Jun 2009)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2017 | Amount | Grant - Afraxis | Valuation |
investors |
|
| Apr, 2012 | Amount | Seed - Afraxis | Valuation |
investors |
|
| Dec, 2011 | Amount | Debt – Conventional - Afraxis | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Afraxis
Afraxis has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Afraxis
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Afraxis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Afraxis Comparisons
Competitors of Afraxis
Afraxis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cellply, Lucid Scientific, Kiyatec, CytoTronics and Saguaro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of in-vitro diagnostic products for the detection of cancer
|
|
| domain | founded_year | HQ Location |
Real-time cell analyzers are developed for oxygen consumption monitoring.
|
|
| domain | founded_year | HQ Location |
Kiyatec is focused on revolutionizing cancer care through predictive platforms.
|
|
| domain | founded_year | HQ Location |
Cell-based assays for drug discovery are developed via CMOS platform.
|
|
| domain | founded_year | HQ Location |
3D cell culture products are developed for drug discovery applications.
|
|
| domain | founded_year | HQ Location |
Metastatic cancer properties are targeted by Remedy Plan's containment therapy.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Afraxis
When was Afraxis founded?
Afraxis was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Where is Afraxis located?
Afraxis is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is Afraxis a funded company?
Afraxis is a funded company, having raised a total of $2M across 5 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $300K, raised on Jun 08, 2009.
What is the annual revenue of Afraxis?
Annual revenue of Afraxis is $403.09K as on Mar 31, 2022.
What does Afraxis do?
Afraxis, founded in 2007 in San Diego, United States, focuses on providing healthcare solutions, producing pharmaceutical products, drug screening, and cns technologies. Provides comprehensive CNS pharmaceutical screening technologies for pre-clinical evaluations. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Who are the top competitors of Afraxis?
Afraxis's top competitors include CytoTronics, Kiyatec and Remedy Plan.
Who are Afraxis's investors?
Afraxis has 1 investor. Key investors include HHS.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.